APGE
Price
$37.87
Change
+$0.74 (+1.99%)
Updated
Sep 5 closing price
Capitalization
2.26B
72 days until earnings call
GENFF
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
5.18M
Interact to see
Advertisement

APGE vs GENFF

Header iconAPGE vs GENFF Comparison
Open Charts APGE vs GENFFBanner chart's image
Apogee Therapeutics
Price$37.87
Change+$0.74 (+1.99%)
Volume$498.29K
Capitalization2.26B
Genflow Biosciences
Price$0.02
Change-$0.00 (-0.00%)
Volume$8K
Capitalization5.18M
APGE vs GENFF Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. GENFF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and GENFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (APGE: $37.87 vs. GENFF: $0.02)
Brand notoriety: APGE and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 62% vs. GENFF: 14%
Market capitalization -- APGE: $2.26B vs. GENFF: $5.18M
APGE [@Biotechnology] is valued at $2.26B. GENFF’s [@Biotechnology] market capitalization is $5.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and GENFF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while GENFF’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 3 bearish.
  • GENFF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GENFF is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +4.12% price change this week, while GENFF (@Biotechnology) price change was -18.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.26B) has a higher market cap than GENFF($5.18M). APGE YTD gains are higher at: -16.402 vs. GENFF (-70.149).
APGEGENFFAPGE / GENFF
Capitalization2.26B5.18M43,546%
EBITDA-270.1MN/A-
Gain YTD-16.402-70.14923%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash505MN/A-
Total Debt10.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGEGENFF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
43%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
45%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GENFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBF28.510.26
+0.92%
PBF Energy
BSET16.80-0.04
-0.24%
Bassett Furniture Industries
TBPH13.95-0.10
-0.71%
Theravance Biopharma
FTS49.23-0.45
-0.91%
Fortis
FLYE0.65-0.01
-1.53%
Fly-E Group Inc

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+1.99%
SYRE - APGE
54%
Loosely correlated
+0.06%
CRNX - APGE
50%
Loosely correlated
+3.97%
IDYA - APGE
48%
Loosely correlated
+5.15%
DYN - APGE
48%
Loosely correlated
+7.40%
IRON - APGE
47%
Loosely correlated
+0.95%
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and TOVX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and TOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
-18.55%
TOVX - GENFF
25%
Poorly correlated
+3.72%
VRCA - GENFF
23%
Poorly correlated
-1.07%
SGMT - GENFF
10%
Poorly correlated
-1.93%
OCS - GENFF
6%
Poorly correlated
+0.35%
APGE - GENFF
3%
Poorly correlated
+1.99%
More